Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
2.025
+0.015 (0.75%)
At close: Aug 11, 2025, 4:00 PM
1.960
-0.065 (-3.21%)
After-hours: Aug 11, 2025, 4:10 PM EDT
Paramount Global Market Cap
Elutia has a market cap or net worth of $83.26 million as of August 11, 2025. Its market cap has decreased by -20.61% in one year.
Market Cap
83.26M
Enterprise Value
88.66M
1-Year Change
-20.61%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $83.26M, a decrease of -52.11%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 82.64M | -36.07% |
| Dec 31, 2024 | 129.26M | 157.97% |
| Dec 29, 2023 | 50.11M | -26.88% |
| Dec 30, 2022 | 68.53M | -19.77% |
| Dec 31, 2021 | 85.42M | -38.72% |
| Dec 31, 2020 | 139.38M | -19.82% |
| Oct 8, 2020 | 173.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |